Coping with hypoxemia: Could erythropoietin (EPO) be an adjuvant treatment of COVID-19?

A very recent epidemiological study provides preliminary evidence that living in habitats located at 2500 m above sea level (masl) might protect from the development of severe respiratory symptoms following infection with the novel SARS-CoV-2 virus. This epidemiological finding raises the question o...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Respir Physiol Neurobiol
Päätekijät: Soliz, Jorge, Schneider-Gasser, Edith M., Arias-Reyes, Christian, Aliaga-Raduan, Fernanda, Poma-Machicao, Liliana, Zubieta-Calleja, Gustavo, Furuya, Werner I., Trevizan-Baú, Pedro, Dhingra, Rishi R., Dutschmann, Mathias
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Elsevier B.V. 2020
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7275159/
https://ncbi.nlm.nih.gov/pubmed/32522574
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.resp.2020.103476
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia